163 related articles for article (PubMed ID: 35995203)
21. Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity
Li W; Wang X; Liu T; Zhang Q; Cao J; Jiang Y; Sun Q; Li C; Wang W; Wang Y
Front Cell Dev Biol; 2022; 10():813370. PubMed ID: 35223843
[TBL] [Abstract][Full Text] [Related]
22. Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway.
Liang L; Tu Y; Lu J; Wang P; Guo Z; Wang Q; Guo K; Lan R; Li H; Liu P
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028181
[TBL] [Abstract][Full Text] [Related]
23. Total flavonoids of Selaginella tamariscina (P.Beauv.) Spring ameliorates doxorubicin-induced cardiotoxicity by modulating mitochondrial dysfunction and endoplasmic reticulum stress via activating MFN2/PERK.
Gao L; Yuan P; Wei Y; Fu Y; Hou Y; Li P; Chen Y; Ruan Y; Zhou N; Zheng X; Feng W
Phytomedicine; 2022 Jun; 100():154065. PubMed ID: 35358932
[TBL] [Abstract][Full Text] [Related]
24. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
25. Doxorubicin induced cardio toxicity through sirtuins mediated mitochondrial disruption.
Ahmad N; Ullah A; Chu P; Tian W; Tang Z; Sun Z
Chem Biol Interact; 2022 Sep; 365():110028. PubMed ID: 35921947
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l-mediated mitochondrial fission.
Aung LHH; Li R; Prabhakar BS; Li P
J Cell Mol Med; 2017 Dec; 21(12):3394-3404. PubMed ID: 28643438
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment.
Sacks B; Onal H; Martorana R; Sehgal A; Harvey A; Wastella C; Ahmad H; Ross E; Pjetergjoka A; Prasad S; Barsotti R; Young LH; Chen Q
BMC Pharmacol Toxicol; 2021 Sep; 22(1):49. PubMed ID: 34530934
[TBL] [Abstract][Full Text] [Related]
28. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
30. Alleviation of doxorubicin-induced cardiomyocyte death through miR-147-y-mediated mitophagy.
Gao H; Xian G; Zhong G; Huang B; Liang S; Zeng Q; Liu Y
Biochem Biophys Res Commun; 2022 Jun; 609():176-182. PubMed ID: 35452958
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
33. Neuraminidase1 Inhibitor Protects Against Doxorubicin-Induced Cardiotoxicity
Qin Y; Lv C; Zhang X; Ruan W; Xu X; Chen C; Ji X; Lu L; Guo X
Front Cell Dev Biol; 2021; 9():802502. PubMed ID: 34977042
[TBL] [Abstract][Full Text] [Related]
34. Ophiopogonin D'-induced mitophagy and mitochondrial damage are associated with dysregulation of the PINK1/Parkin signaling pathway in AC16 cells.
Lei S; Feng Y; Huang P; Chen B; Bao K; Wu Q; Zhang H; Huang X
Toxicology; 2022 Jul; 477():153275. PubMed ID: 35905946
[TBL] [Abstract][Full Text] [Related]
35. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
[TBL] [Abstract][Full Text] [Related]
36. Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.
Dhingra R; Guberman M; Rabinovich-Nikitin I; Gerstein J; Margulets V; Gang H; Madden N; Thliveris J; Kirshenbaum LA
Cardiovasc Res; 2020 May; 116(6):1161-1174. PubMed ID: 31566215
[TBL] [Abstract][Full Text] [Related]
37. Enhanced mitophagy mediated by the YAP/Parkin pathway protects against DOX-induced cardiotoxicity.
Xiao D; Chang W; Ding W; Wang Y; Fa H; Wang J
Toxicol Lett; 2020 May; 330():96-107. PubMed ID: 32434049
[TBL] [Abstract][Full Text] [Related]
38. Vascular Endothelial Cell-Derived Exosomal Sphingosylphosphorylcholine Attenuates Myocardial Ischemia-Reperfusion Injury through NR4A2-Mediated Mitophagy.
Yu Y; Li Z; Cai Y; Guo J; Lin Y; Zhao J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542280
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts.
Mancilla TR; Davis LR; Aune GJ
PLoS One; 2020; 15(9):e0238856. PubMed ID: 32960902
[TBL] [Abstract][Full Text] [Related]
40. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB
Cell Biol Toxicol; 2009 Jun; 25(3):227-43. PubMed ID: 18386138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
